OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy (Alliance)
- Citation:
- Meeting Instance:
- SABCS 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180863 (CCTG);
- Corr. Author:
- Authors:
- Sara M. Tolaney Karla Ballman Charles Perou David Cescon Margaret Gatti-Mays Victoria Blinder Shoshana Rosenberg Elizabeth A. Mittendorf Anna Weiss Hope Rugo Alice Ho Dana Casey Baljit Singh Fabrice Smieliauskas Yara Abdou Vijay Damarla Jane Meisel Lisa Carey Ann H. Partridge
- Networks:
- 11030, CA016, CA824, HEARTLAND, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-OH007, MI020, NY018, NY167
- Study
- Alliance-A012103
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: